MarketCapExport financials
Coty (COTY)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Coty Income Statement 2026-2011 | COTY
Brief overview of financial performance at Coty
The overview follows changes across a five-year period. According to figures from Coty, revenue changed from 4.7 billion dollars to 5.9 billion dollars over five years. Across the full period, sales moved by +24.9%; the average annual rate was 4.5%. The business did not achieve meaningful top-line expansion.
The gross result shifted from $2.7 billion to $3.8 billion, or +40.1%. Cost of revenue developed more favorably than sales, supporting gross profitability. The gross margin was 57.8% at the start and 64.8% at the end. The business retained more gross profit from each unit of revenue.
Over the period, EBITDA shifted from −520 million dollars to 661 million dollars, a change of +227.1%. Operating profitability strengthened faster than the scale of sales. EBITDA margin was −11% at the start and 11.2% at the end. The company improved its ability to convert sales into EBITDA.
The net financial result changed from −$1 billion to −$368 million. The negative result improved without reaching break-even.
Market capitalization changed from 5.3 billion dollars to 3.3 billion dollars (−37.6%). Financial performance is stronger than the share-price trend.
Overall conclusion
The results present an uneven picture without one dominant signal. The strongest signals are positive operating leverage, a stronger final result and improving gross profitability. The weaker side of the profile includes declining capitalization and weak sales momentum. The next reporting periods will show whether revenue, margins, and final profitability can strengthen.
Annual Income Statement Coty
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
2.41 B | 3.32 B | 8.33 B | 9.1 B | 6.2 B | 7.01 B | 5.82 B | 8.41 B | 10.1 B | 13.2 B | 9.28 B | 9.51 B | 6.49 B | 6.54 B | - | - |
Shares |
877 M | 871 M | 874 M | 849 M | 821 M | 765 M | 759 M | 751 M | 750 M | 643 M | 346 M | 353 M | 382 M | 382 M | - | - |
Historical Prices |
2.75 | 3.81 | 9.53 | 10.7 | 7.55 | 9.17 | 7.67 | 9.13 | 10.4 | 17.6 | 16.5 | 24.8 | 19.5 | 12.6 | - | - |
Net Income |
-618 M | -381 M | 76.2 M | 495 M | 55.5 M | -201 M | -1.01 B | -3.78 B | -169 M | -422 M | 157 M | 232 M | -97.4 M | 168 M | -324 M | 61.7 M |
Revenue |
5.81 B | 5.89 B | 6.12 B | 5.55 B | 5.3 B | 4.63 B | 4.72 B | 8.65 B | 9.4 B | 7.65 B | 4.35 B | 4.4 B | 4.55 B | 4.65 B | 4.61 B | 4.09 B |
Cost of Revenue |
2.15 B | 2.07 B | 2.18 B | 2.01 B | 1.94 B | 1.86 B | 1.99 B | 2.5 B | 2.72 B | 3.03 B | - | - | - | - | - | - |
Gross Profit |
3.65 B | 3.82 B | 3.94 B | 3.55 B | 3.37 B | 2.77 B | 2.73 B | 5.34 B | 5.79 B | 4.62 B | 2.6 B | 2.64 B | 2.69 B | 2.79 B | 2.79 B | 2.45 B |
Operating Income |
-81.5 M | 241 M | 547 M | 544 M | 241 M | -48.6 M | -1.24 B | -3.69 B | -156 M | -421 M | 254 M | 395 M | 25.7 M | 394 M | -210 M | - |
Interest Expense |
-374 M | -372 M | -90.2 M | 261 M | 241 M | 232 M | 233 M | 252 M | 223 M | 220 M | 113 M | 71.4 M | 69.8 M | 77.2 M | 81.8 M | - |
EBITDA |
401 M | 661 M | 968 M | 970 M | 757 M | 537 M | -520 M | 778 M | 780 M | 562 M | 575 M | 572 M | 466 M | 505 M | 488 M | 412 M |
Operating Expenses |
3.73 B | 3.58 B | 3.39 B | 3 B | 3.13 B | 2.82 B | 3.96 B | 4.92 B | 5.36 B | 4.34 B | 2.11 B | 2.14 B | 2.31 B | 2.37 B | 2.4 B | 2.11 B |
General and Administrative Expenses |
3.11 B | 3.1 B | 3.16 B | 2.82 B | 2.88 B | 2.36 B | 3.12 B | - | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Income Statement Coty
| 2027-Q1 | 2026-Q4 | 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
881 M | 900 M | 880 M | 877 M | 873 M | 500 M | 872 M | 871 M | 868 M | -2.3 M | 883 M | 893 M | 854 M | 900 M | 852 M | 851 M | 842 M | 5.8 M | 838 M | 829 M | 778 M | 200 M | 765 M | 765 M | 764 M | 1.4 M | 761 M | 758 M | 754 M | 100 K | 751 M | 751 M | 751 M | 300 M | 750 M | 750 M | 749 M | 34.9 M | 747 M | 747 M | 336 M | -2.3 M | 338 M | 345 M | 360 M | 2.4 M | 345 M | 353 M | 354 M | -2.4 M | 384 M | 384 M | 384 M | 384 M | 384 M | 384 M | 384 M | 381 M | 380 M | - | - | - | - | - | - |
Net Income |
106 M | -144 M | -411 M | -127 M | 64.6 M | -72.1 M | -409 M | 20.4 M | 79.6 M | -100 M | 500 K | 178 M | -1.7 M | 29.6 M | 105 M | 235 M | 125 M | -285 M | 50.3 M | 193 M | 103 M | -210 M | -18.5 M | -275 M | 201 M | -773 M | -272 M | -21.1 M | 52.3 M | -2.81 B | -4 M | -956 M | -10.1 M | -211 M | -60.1 M | 119 M | -16.1 M | -301 M | -159 M | 52.1 M | 9.8 M | -31.2 M | -20.3 M | 97.6 M | 133 M | 25.6 M | 82.2 M | 135 M | 16.7 M | -12.8 M | -247 M | 93.1 M | 102 M | 82.5 M | 93.5 M | 82.5 M | 93.5 M | 123 M | 86.7 M | - | - | - | - | - | - |
Revenue |
1.56 B | 1.27 B | 1.28 B | 1.68 B | 1.58 B | 1.25 B | 1.3 B | 1.67 B | 1.67 B | 1.36 B | 1.39 B | 1.73 B | 1.64 B | 1.35 B | 1.29 B | 1.52 B | 1.39 B | 1.17 B | 1.19 B | 1.58 B | 1.37 B | 1.06 B | 1.03 B | 1.42 B | 1.12 B | 560 M | 1.06 B | 1.68 B | 1.41 B | -245 M | 1.99 B | 2.51 B | 2.03 B | -257 M | 2.22 B | 2.64 B | 2.24 B | 2.64 B | 2.24 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
570 M | 496 M | 490 M | 608 M | 560 M | 473 M | 467 M | 556 M | 577 M | 488 M | 488 M | 604 M | 600 M | 502 M | 478 M | 525 M | 501 M | 446 M | 423 M | 561 M | 505 M | 421 M | 392 M | 584 M | 465 M | 336 M | 461 M | 632 M | 562 M | -8.5 M | 741 M | 957 M | 809 M | 6.8 M | 812 M | 1.02 B | 874 M | 1.02 B | 874 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
985 M | 773 M | 792 M | 1.07 B | 1.02 B | 780 M | 832 M | 1.11 B | 1.09 B | 875 M | 898 M | 1.12 B | 1.04 B | 850 M | 811 M | 998 M | 889 M | 722 M | 763 M | 1.02 B | 867 M | 641 M | 636 M | 832 M | 659 M | 224 M | 602 M | 1.05 B | 849 M | -237 M | 1.25 B | 1.55 B | 1.22 B | -264 M | 1.41 B | 1.61 B | 1.36 B | 1.37 B | 1.22 B | 1.4 B | 635 M | 610 M | 582 M | 743 M | 669 M | 605 M | 582 M | 751 M | 700 M | 593 M | 613 M | 774 M | 706 M | 774 M | 706 M | 774 M | 706 M | 817 M | 737 M | - | - | - | - | - | - |
Operating Income |
170 M | -42.7 M | -372 M | 148 M | 185 M | 15.5 M | -280 M | 268 M | 238 M | 34.7 M | 77.8 M | 237 M | 198 M | 129 M | 43.5 M | 199 M | 172 M | -77.4 M | 57.1 M | 244 M | 17.2 M | 1.8 M | -1.4 M | 17 M | -66 M | -920 M | -300 M | -80.5 M | 64 M | -2.95 B | 85.5 M | -805 M | -20.7 M | -381 M | 20.7 M | 175 M | 29.5 M | -262 M | -192 M | -12.7 M | 46.4 M | -2.9 M | 23 M | 152 M | 81.7 M | -23.4 M | 115 M | 184 M | 120 M | -11.4 M | -272 M | 144 M | 166 M | 144 M | 166 M | 144 M | 166 M | 222 M | 166 M | - | - | - | - | - | - |
Interest Expense |
18.2 M | -13.6 M | -53.2 M | -275 M | -31.3 M | -38.9 M | -132 M | -157 M | -43.3 M | 100 M | -60.4 M | -60.1 M | -69.8 M | -72.2 M | -58.8 M | -61 M | -65.9 M | -40.4 M | -62.9 M | -60.9 M | -59.8 M | -63.5 M | -50.3 M | -59.2 M | -62.1 M | -57.4 M | -63.8 M | -58.4 M | -63.1 M | -20.8 M | -72 M | -68.3 M | -64.1 M | -1.3 M | -72.6 M | -60.3 M | -66.4 M | -59.5 M | -60.8 M | -57.9 M | -40.4 M | -26.2 M | -25.1 M | -14.6 M | -16 M | -16.7 M | -17.6 M | -19.1 M | -19.6 M | -17.1 M | -17.3 M | -16.7 M | -17.4 M | 17.5 M | 17.4 M | 200 K | 20.1 M | 200 K | 200 K | - | - | - | - | - | - |
EBITDA |
204 M | 31.4 M | -298 M | 222 M | 224 M | 61.1 M | -234 M | 316 M | 286 M | 82.7 M | 126 M | 285 M | 246 M | 178 M | 91.7 M | 247 M | 219 M | -28.6 M | 107 M | 295 M | 74.2 M | 63.6 M | 60.8 M | 78.8 M | -600 K | -858 M | -238 M | -29.7 M | 122 M | -2.97 B | 172 M | -716 M | 71.8 M | -397 M | 114 M | 265 M | 108 M | -206 M | -89.9 M | 82.4 M | 67.6 M | 17.6 M | 43.9 M | 171 M | 101 M | 37.4 M | 133 M | 202 M | 179 M | 51.1 M | -210 M | 205 M | 230 M | 144 M | 230 M | 270 M | 230 M | 222 M | 227 M | - | - | - | - | - | - |
Operating Expenses |
814 M | 815 M | 1.16 B | 922 M | 832 M | 764 M | 1.11 B | 846 M | 857 M | 841 M | 820 M | 887 M | 844 M | 720 M | 767 M | 799 M | 717 M | 800 M | 706 M | 773 M | 850 M | 640 M | 638 M | 815 M | 725 M | 1.14 B | 901 M | 1.13 B | 785 M | 2.71 B | 1.16 B | 2.36 B | 1.24 B | 117 M | 1.39 B | 1.44 B | 1.33 B | 1.63 B | 1.41 B | 1.42 B | 589 M | 613 M | 559 M | 590 M | 587 M | 629 M | 467 M | 567 M | 580 M | 604 M | 885 M | 630 M | 541 M | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
780 M | 745 M | 727 M | 842 M | 794 M | 721 M | 778 M | 797 M | 808 M | 791 M | 771 M | 833 M | 767 M | 673 M | 720 M | 754 M | 671 M | 727 M | 659 M | 719 M | 776 M | 593 M | 546 M | 642 M | 583 M | 639 M | 758 M | 916 M | 807 M | -8.9 M | 1.07 B | 1.28 B | 1.12 B | 45.2 M | 1.25 B | 1.32 B | 1.19 B | 1.3 B | 1.09 B | 1.17 B | 479 M | 534 M | 494 M | 515 M | 484 M | 566 M | 445 M | 535 M | 521 M | 557 M | 543 M | 603 M | 516 M | 603 M | 516 M | 603 M | 516 M | 591 M | 549 M | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
The income statement is one of the three key financial reports of a company Coty (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Reports on the profits and losses of other stocks in the Household products industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
The Clorox Company
CLX
|
$ 106.6 | 1.01 % | $ 12.9 B |  USA |
 |
The Estée Lauder Companies
EL
|
$ 113.35 | 0.17 % | $ 41.1 B | USA |
 |
Unilever PLC
UL
|
$ 66.48 | -0.2 % | $ 145 B |  Britain |
 |
Colgate-Palmolive Company
CL
|
$ 98.06 | 0.12 % | $ 79.3 B | USA |
 |
The Procter & Gamble Company
PG
|
$ 168.81 | 0.29 % | $ 394 B | USA |
 |
United-Guardian
UG
|
$ 9.01 | 1.81 % | $ 41.4 M | USA |
 |
USANA Health Sciences
USNA
|
$ 13.1 | -5.42 % | $ 243 M | USA |
 |
Revlon
REV
|
- | -4.41 % | $ 212 M | USA |
 |
Church & Dwight Co.
CHD
|
$ 111.77 | 0.41 % | $ 27.1 B | USA |
 |
Kimberly-Clark Corporation
KMB
|
$ 110.78 | -1.03 % | $ 36.8 B | USA |
 |
Hims & Hers Health
HIMS
|
$ 19.1 | -16.76 % | $ 4.3 B | USA |
 |
e.l.f. Beauty
ELF
|
$ 118.5 | -0.71 % | $ 6.9 B | USA |
 |
Dogness (International) Corporation
DOGZ
|
$ 0.44 | -1.36 % | $ 7.84 M |  China |
 |
Helen of Troy Limited
HELE
|
$ 38.19 | 2.28 % | $ 878 M |  Bermuda |
 |
Newell Brands
NWL
|
$ 5.94 | 0.76 % | $ 2.48 B | USA |
 |
Acme United Corporation
ACU
|
$ 70.35 | 1.6 % | $ 266 M | USA |
 |
Edgewell Personal Care Company
EPC
|
$ 29.61 | 0.25 % | $ 1.41 B | USA |
 |
LifeVantage Corporation
LFVN
|
$ 4.64 | -12.29 % | $ 58.2 M | USA |
 |
Mannatech, Incorporated
MTEX
|
$ 8.62 | -3.69 % | $ 16.4 M | USA |
 |
Inter Parfums
IPAR
|
$ 135.62 | -0.4 % | $ 4.35 B | USA |
 |
Nature's Sunshine Products
NATR
|
$ 10.89 | -1.23 % | $ 196 M | USA |
 |
Nu Skin Enterprises
NUS
|
$ 4.04 | -5.61 % | $ 199 M | USA |
 |
Natura &Co Holding S.A.
NTCO
|
- | - | $ 9.02 B | - |
 |
Spectrum Brands Holdings
SPB
|
$ 88.66 | -0.75 % | $ 2.28 B | USA |